Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced approach that could help with treatment

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli Lilly's rival drug Zepbound,

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that question. This group, called the Lancet Commission, and organised by the journal of that name, have developed a better way of diagnosing obesity—one that distinguishes when it has become pathological.

Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema

A study has highlighted the significance of fitness over weight for a long life. Researchers revealed that unfit individuals face a higher risk of early death irrespective of their body weight.

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes an approach that looks at how excess body fat affects health

Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition causes ill-health, according to a new framework drawn up by experts and endorsed by 76 medical organizations internationally.

A group of experts from around the world are proposing an alternative way of defining clinical obesity, eschewing the commonly referenced body max index (BMI) and instead approaching the condition